Literature DB >> 22721713

Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines.

Jean-Yves Winum1, Fabrizio Carta, Carol Ward, Peter Mullen, David Harrison, Simon P Langdon, Alessandro Cecchi, Andrea Scozzafava, Ian Kunkler, Claudiu T Supuran.   

Abstract

A series of 50 sulfamates were obtained by reacting 4-aminophenol with isocyanates followed by sulfamoylation. Most of the new compounds were nanomolar inhibitors of the tumor-associated carbonic anhydrase (CA, EC 4.2.1.1) isoforms IX and XII, whereas they inhibited less cytosolic offtarget isoforms CA I and II. Some of these sulfamates showed significant antiproliferative activity in several breast cancer cell lines, such as SKBR3, MCF10A, ZR75/1, MDA-MB-361 and MCF7, constituting interesting anticancer leads.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721713     DOI: 10.1016/j.bmcl.2012.05.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.

Authors:  Mikhail Krasavin; Stanislav Kalinin; Tatiana Sharonova; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

2.  Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.

Authors:  James Meehan; Carol Ward; Arran Turnbull; Jimi Bukowski-Wills; Andrew J Finch; Edward J Jarman; Chrysi Xintaropoulou; Carlos Martinez-Perez; Mark Gray; Matthew Pearson; Peter Mullen; Claudiu T Supuran; Fabrizio Carta; David J Harrison; Ian H Kunkler; Simon P Langdon
Journal:  Oncotarget       Date:  2017-06-27

Review 3.  Carbonic Anhydrases: Role in pH Control and Cancer.

Authors:  Mam Y Mboge; Brian P Mahon; Robert McKenna; Susan C Frost
Journal:  Metabolites       Date:  2018-02-28

Review 4.  Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.

Authors:  Carol Ward; James Meehan; Mark Gray; Ian H Kunkler; Simon P Langdon; David J Argyle
Journal:  Metabolites       Date:  2018-02-10

5.  Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model.

Authors:  Tineke W H Meijer; Johan Bussink; Miriam Zatovicova; Paul N Span; Jasper Lok; Claudiu T Supuran; Johannes H A M Kaanders
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

6.  Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.

Authors:  Carol Ward; James Meehan; Peter Mullen; Claudiu Supuran; J Michael Dixon; Jeremy S Thomas; Jean-Yves Winum; Philippe Lambin; Ludwig Dubois; Nanda-Kumar Pavathaneni; Edward J Jarman; Lorna Renshaw; In Hwa Um; Charlene Kay; David J Harrison; Ian H Kunkler; Simon P Langdon
Journal:  Oncotarget       Date:  2015-09-22

7.  The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.

Authors:  Simon J A van Kuijk; Roben G Gieling; Raymon Niemans; Natasja G Lieuwes; Rianne Biemans; Brian A Telfer; Guido R M M Haenen; Ala Yaromina; Philippe Lambin; Ludwig J Dubois; Kaye J Williams
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma.

Authors:  Olga Kuchuk; Alessandra Tuccitto; Davide Citterio; Veronica Huber; Chiara Camisaschi; Massimo Milione; Barbara Vergani; Antonello Villa; Malcolm Ronald Alison; Simone Carradori; Claudiu T Supuran; Licia Rivoltini; Chiara Castelli; Vincenzo Mazzaferro
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

9.  Novel Sulfamide-Containing Compounds as Selective Carbonic Anhydrase I Inhibitors.

Authors:  Emanuela Berrino; Silvia Bua; Mattia Mori; Maurizio Botta; Vallabhaneni S Murthy; Vijayaparthasarathi Vijayakumar; Yasinalli Tamboli; Gianluca Bartolucci; Alessandro Mugelli; Elisabetta Cerbai; Claudiu T Supuran; Fabrizio Carta
Journal:  Molecules       Date:  2017-06-24       Impact factor: 4.411

10.  Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes.

Authors:  Ashok Aspatwar; Holger M Becker; Nanda Kumar Parvathaneni; Milka Hammaren; Aleksandra Svorjova; Harlan Barker; Claudiu T Supuran; Ludwig Dubois; Philippe Lambin; Mataleena Parikka; Seppo Parkkila; Jean-Yves Winum
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.